VERA Logo

Vera Therapeutics, Inc. (VERA) 

NASDAQ$27.99
Market Cap
$1.78B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
901 of 924
Rank in Industry
515 of 527

VERA Insider Trading Activity

VERA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$53,132,99326100

Related Transactions

SEIDENBERG BETH Cdirector0$03$1.42M$-1.42M
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR0$03$1.53M$-1.53M
Grant SeanCHIEF FINANCIAL OFFICER0$01$4.69M$-4.69M
Fordyce MarshallPRESIDENT AND CEO0$016$11.39M$-11.39M
Katabi Mahadirector0$03$34.1M$-34.1M

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode â€¦

Insider Activity of Vera Therapeutics, Inc.

Over the last 12 months, insiders at Vera Therapeutics, Inc. have bought $0 and sold $53.13M worth of Vera Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Vera Therapeutics, Inc. have bought $59.02M and sold $25.29M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 161,290 shares for transaction amount of $5M was made by Katabi Maha (director) on 2024‑01‑30.

List of Insider Buy and Sell Transactions, Vera Therapeutics, Inc.

2025-02-26SaleFordyce MarshallPRESIDENT AND CEO
9,075
0.0145%
$27.65$250,882+1.02%
2025-02-21SaleFordyce MarshallPRESIDENT AND CEO
10,613
0.0158%
$27.89$296,032-1.36%
2025-01-08SaleFordyce MarshallPRESIDENT AND CEO
17,500
0.0275%
$41.74$730,535-20.51%
2024-12-18SaleFordyce MarshallPRESIDENT AND CEO
17,500
0.0289%
$43.07$753,680-17.36%
2024-12-18SaleFordyce MarshallPRESIDENT AND CEO
15,625
0.0257%
$42.98$671,536-17.36%
2024-12-18SaleFordyce MarshallPRESIDENT AND CEO
3,772
0.006%
$41.33$155,883-17.36%
2024-12-11SaleFordyce MarshallPRESIDENT AND CEO
17,500
0.0277%
$46.94$821,523-25.36%
2024-11-25SaleFordyce MarshallPRESIDENT AND CEO
19,375
0.0313%
$47.98$929,560-22.70%
2024-11-13SaleFordyce MarshallPRESIDENT AND CEO
30,625
0.048%
$49.50$1.52M-24.18%
2024-10-28SaleSEIDENBERG BETH Cdirector
15,000
0.0323%
$48.03$720,493-12.63%
2024-10-23SaleFordyce MarshallPRESIDENT AND CEO
19,375
0.0351%
$40.39$782,610+3.35%
2024-10-09SaleFordyce MarshallPRESIDENT AND CEO
15,625
0.0239%
$38.24$597,568+4.80%
2024-09-25SaleFordyce MarshallPRESIDENT AND CEO
22,225
0.0419%
$46.02$1.02M-9.03%
2024-09-19SaleSEIDENBERG BETH Cdirector
13,823
0.0254%
$42.31$584,793-2.06%
2024-09-18SaleSEIDENBERG BETH Cdirector
2,653
0.005%
$42.01$111,440+2.06%
2024-09-11SaleFordyce MarshallPRESIDENT AND CEO
15,625
0.0285%
$37.50$585,934+8.77%
2024-08-28SaleFordyce MarshallPRESIDENT AND CEO
30,320
0.0555%
$36.84$1.12M+10.03%
2024-08-21SaleFordyce MarshallPRESIDENT AND CEO
14,471
0.0263%
$39.76$575,425+0.66%
2024-08-14SaleFordyce MarshallPRESIDENT AND CEO
15,625
0.03%
$37.56$586,927+5.80%
2024-05-16SaleYoung Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
20,651
0.037%
$42.32$873,890-9.41%
Total: 97
*Gray background shows transactions not older than one year

Insider Historical Profitability

80.63%
Katabi Mahadirector
2793987
4.3828%
$78.2M23+37.14%
SEIDENBERG BETH Cdirector
131553
0.2064%
$3.68M193+96.79%
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
51206
0.0803%
$1.43M23+91.54%
Grant SeanCHIEF FINANCIAL OFFICER
0
0%
$041+48.2%
COMMODORE CAPITAL LP10 percent owner
4400000
6.9021%
$123.16M11+19.9%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$66,492,695
135
27.65%
$2.04B
$831,902,292
108
9.34%
$1.58B
$20,297,544
73
103.06%
$1.61B
$11,583,737
45
49.75%
$1.75B
$224,267,561
40
26.78%
$2.17B

VERA Institutional Investors: Active Positions

Increased Positions134+100.75%13M+25.23%
Decreased Positions60-45.11%4M-7.28%
New Positions33New2MNew
Sold Out Positions25Sold Out690,705Sold Out
Total Postitions207+55.64%63M+17.95%

VERA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Avoro Capital Advisors Llc$167,907.008.9%5.61M+1M+30.18%2024-12-31
Price T Rowe Associates Inc /Md/$131,005.006.95%4.38M+437,940+11.12%2024-12-31
Blackrock, Inc.$117,969.006.26%3.94M+489,284+14.17%2024-12-31
Fmr Llc$91,380.004.85%3.05M+267,842+9.62%2024-12-31
Vanguard Group Inc$88,280.004.68%2.95M+369,387+14.32%2024-12-31
Sofinnova Investments, Inc.$83,624.004.43%2.79M00%2024-12-31
State Street Corp$60,649.003.22%2.03M+202,545+11.11%2024-12-31
Commodore Capital Lp$58,621.003.11%1.96M-516,400-20.86%2024-12-31
Holocene Advisors, Lp$56,148.002.98%1.88M-78,565-4.02%2024-12-31
Samlyn Capital, Llc$49,750.002.64%1.66M+302,993+22.29%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.85SellsBuysStrong BuyBuyHoldSellStrong SellVERAHighAverageLowSeries 4